This inventor holds 1 USPTO granted patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Gregor Mlinsek: Innovator in Thrombin Inhibition
Introduction
Gregor Mlinsek is a notable inventor based in Skofja Loka, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of thrombin inhibitors. His work is characterized by a commitment to advancing medical science through innovative solutions.
Latest Patents
Gregor Mlinsek holds a patent for "Amidinophenylalanine derivatives as thrombin inhibitors." This patent describes compounds that serve as thrombin inhibitors, including a detailed process for their preparation and pharmaceutical compositions containing these compounds. The compounds are defined by specific substituents, which are elaborated in the patent description. He has 1 patent to his name.
Career Highlights
Gregor Mlinsek is currently employed at Lek Pharmaceuticals D.d., a prominent pharmaceutical company. His role at Lek Pharmaceuticals allows him to apply his expertise in drug development and contribute to the advancement of therapeutic options in the medical field.
Collaborations
Gregor has collaborated with notable colleagues, including Uros Urleb and Anamarija Zega. These partnerships enhance the innovative capacity of his work and contribute to the success of their projects.
Conclusion
Gregor Mlinsek is a distinguished inventor whose work in thrombin inhibitors exemplifies the intersection of innovation and healthcare. His contributions continue to impact the pharmaceutical industry positively.